Der Hautarzt

, Volume 61, Issue 6, pp 497–504 | Cite as

α-Melanozyten-stimulierendes Hormon

Von der Forschung in die Klinik
  • M. BöhmEmail author
  • T.A. Luger


α-Melanozyten-stimulierendes Hormon (α-MSH) ist ein Tridekapeptid, das in der Haut selbst aus dem Präkursor Proopiomelanokortin gebildet wird. Es vermittelt Ultraviolett-Licht-vermittelte Pigmentierung nach Binding an Melanokortin-1-Rezeptoren (MC-1R), die u. a. auf der Oberfläche von epidermalen Melanozyten exprimiert sind. Die pigmentinduzierende und zytoprotektive Wirkung von α-MSH bildet das Rationale für den ersten klinischen Einsatz eines subkutan applizierbaren synthetischen und superpotenten α-MSH-Analogons, Nle4-D-Phe7-α-MSH (NDP-α-MSH), in Phase-II-Studien bei Patienten mit Photodermatosen, z. B. der erythropoietischen Protoporphyrie. Da α-MSH in einer Reihe von präklinischen Untersuchungen neben seiner melanotropen Wirkung auch vielversprechende antiinflammatorische und antifibrotische Effekte gezeigt hat, wird es von großem Interesse sein, diese Eigenschaften anhand weiterer klinischer Pilotstudien mit NDP-α-MSH zu überprüfen. Neben synthetischen α-MSH-Analoga bieten darüber hinaus Tripeptid-Derivate wie KdPT, die nicht an MC-1R binden, aber erhaltene antiinflammatorische Eigenschaften haben, eine weitere neue therapeutische Strategie in der Dermatologie.


Afamelanotide α-Melanozyten-stimulierendes Hormon Melanokortin-Rezeptoren Pigmentierung Proopiomelanokortin 

α-Melanocyte-stimulating hormone

From bench to bedside


α-Melanocyte-stimulating hormone (α-MSH) is a tridecapeptide that is produced by the skin itself from the precursor proopiomelanocortin. It crucially mediates ultraviolet light-induced tanning after binding to melanocortin-1 receptors (MC-1R) expressed on the surface of epidermal melanocytes. The potent pigment-inducing and also cytoprotective actions of α-MSH are the rationale for the performance of first phase II clinical trials with Nle4-D-Phe7-α-MSH (NDP-α-MSH), a subcutaneously administered synthetic and superpotent α-MSH analogue, in patients with photodermatoses such as erythropoietic protoporphyria. Since α-MSH has shown promising anti-inflammatory and antifibrotic properties in numerous preclinical studies, it will be most interesting to evaluate these effects in further clinical pilot studies with NDP-α-MSH. In addition to α-MSH analogues, truncated tripeptides such as KDPT which do not bind to MC-1R but have sustained anti-inflammatory properties are currently emerging as another novel therapeutic strategy in dermatology.


Afamelanotide α-Melanocyte-stimulating hormone Melanocortin receptors Pigmentation Proopiomelanocortin 



Der korrespondierende Autor gibt an, dass kein Interessenkonflikt besteht.


  1. 1.
    Abdel-Malek ZA, Ruwe A, Kavanagh-Starner R et al (2009) Alpha-MSH tripeptide analogs activate the melanocortin 1 receptor and reduce UV-induced DNA damage in human melanocytes. Pigment Cell Melanoma Res 22:635–644CrossRefPubMedGoogle Scholar
  2. 2.
    Barnetson RS, Ooi TK, Zhuang L et al (2006) [Nle4-D-Phe7]-alpha-melanocyte-stimulating hormone significantly increased pigmentation and decreased UV damage in fair-skinned Caucasian volunteers. J Invest Dermatol 126:1869–1878CrossRefPubMedGoogle Scholar
  3. 3.
    Böhm M, Schiller M, Stadler R et al (2001) Diffuse melanosis arising from metastatic melanoma: pathogenetic function of elevated melanocyte peptide growth factors. J Am Acad Dermatol 44:747–754CrossRefPubMedGoogle Scholar
  4. 4.
    Böhm M, Luger TA, Tobin DJ, García-Borrón JC (2006) Melanocortin receptor ligands: new horizons for skin biology and clinical dermatology. J Invest Dermatol 126:1966–1975CrossRefPubMedGoogle Scholar
  5. 5.
    Böhm M, Raghunath M, Sunderkötter C et al (2004) Collagen metabolism is a novel target of the neuropeptide α-melanocyte-stimulating hormone. J Biol Chem 279:6959–6966CrossRefPubMedGoogle Scholar
  6. 6.
    Böhm M, Wolff I, Scholzen TE et al (2005) Alpha-melanocyte-stimulating hormone protects from ultraviolet radiation-induced apoptosis and DNA damage. J Biol Chem 280:5795–5802CrossRefPubMedGoogle Scholar
  7. 7.
    Brzoska T, Luger TA, Maaser C et al (2008) α-melanocyte-stimulating hormone and related tripeptides. Biochemistry, anti-inflammatory and protective effects in vitro and in vivo and future perspectives for the treatment of immune-mediated inflammatory diseases. Endocr Rev 29:581–602CrossRefPubMedGoogle Scholar
  8. 8.
    Clément K, Dubern B, Mencarelli M et al (2008) Unexpected endocrine features and normal pigmentation in a young adult patient carrying a novel homozygous mutation in the POMC gene. J Clin Endocrinol Metab 93:4955–4962CrossRefPubMedGoogle Scholar
  9. 9.
    Cui R, Widlund HR, Feige E et al (2007) Central role of p53 in the suntan response and pathologic hyperpigmentation. Cell 128:853–864CrossRefPubMedGoogle Scholar
  10. 10.
    Ferreira SH, Lorenzetti BB, Bristow AF, Poole S (1988) Interleukin-1 beta as a potent hyperalgesic agent antagonized by a tripeptide analogue. Nature 334:698–700CrossRefPubMedGoogle Scholar
  11. 11.
    Hadley ME, Dorr RT (2006) Melanocortin peptide therapeutics: historical milestones, clinical studies and commercialization. Peptides 27:921–930CrossRefPubMedGoogle Scholar
  12. 12.
    Harms J, Lautenschlager S, Minder CE, Minder EI (2009) An alpha-melanocyte-stimulating hormone analogue in erythropoietic protoporphyria. N Engl J Med 360:306–307CrossRefPubMedGoogle Scholar
  13. 13.
    Harms JH, Lautenschlager S, Minder CE, Minder EI (2009) Mitigating photosensitivity of erythropoietic protoporphyria patients by an agonistic analog of alpha-melanocyte stimulating hormone. Photochem Photobiol 85:1434–1439CrossRefPubMedGoogle Scholar
  14. 14.
    Ito T, Ito N, Bettermann A et al (2004) Collapse and restoration of MHC class-I-dependent immune privilege: exploiting the human hair follicle as a model. Am J Pathol 164:623–634PubMedGoogle Scholar
  15. 15.
    Kadekaro AL, Kavanagh R, Kanto H et al (2005) Alpha-Melanocortin and endothelin-1 activate antiapoptotic pathways and reduce DNA damage in human melanocytes. Cancer Res 65:4292–4299CrossRefPubMedGoogle Scholar
  16. 16.
    Kokot A, Metze D, Mouchet N et al (2009) α-MSH counteracts the suppressive effect of UVB on Nrf2 and Nrf-dependent gene expression in human skin. Endocrinology 150:3197–3206CrossRefPubMedGoogle Scholar
  17. 17.
    Kokot A, Sindrilaru A, Schiller M et al (2009) α-Melanocyte-stimulating hormone suppresses bleomycin-induced collagen synthesis and reduces tissue fibrosis in a mouse model of scleroderma. Arthritis Rheum 60:592–603CrossRefPubMedGoogle Scholar
  18. 18.
    Krude H, Biebermann, Luck W et al (1998) Severe early-onset obesity, adrenal insufficiency and red hair pigmentation caused by POMC mutations in humans. Nat Genet 19:155–157CrossRefPubMedGoogle Scholar
  19. 19.
    Loser K, Brzoska T, Oji V et al (2010) The neuropeptide alpha-melanocyte-stimulating hormone is critically involved in the development of cytotoxic CD8+ T cells in mice and humans. PLoS One 5:e8958CrossRefPubMedGoogle Scholar
  20. 20.
    Mountjoy KG, Robbins LS, Mortrud MT, Cone RD (1992) The cloning of a family of genes that encode the melanocortin receptors. Science 257:1248–1251CrossRefPubMedGoogle Scholar
  21. 21.
    Park HY, Kosmadaki M, Yaar M, Gilchrest BA (2009) Cellular mechanisms regulating human melanogenesis. Cell Mol Life Sci 66:1493–1506CrossRefPubMedGoogle Scholar
  22. 22.
    Pérez Oliva AB, Fernéndez LP, Detorre C et al (2009) Identification and functional analysis of novel variants of the human melanocortin 1 receptor found in melanoma patients. Hum Mutat 30:811–822CrossRefGoogle Scholar
  23. 23.
    Rousseau K, Kauser S, Pritchard LE et al (2007) Proopiomelanocortin (POMC), the ACTH/melanocortin precursor, is secreted by human epidermal keratinocytes and melanocytes and stimulates melanogenesis. FASEB J 21:1844–1856CrossRefPubMedGoogle Scholar
  24. 24.
    Sawyer TK, Sanfilippo PJ, Hruby VJ et al (1980) 4-Norleucine, 7-D-phenylalanine-alpha-melanocyte-stimulating hormone: a highly potent alpha-melanotropin with ultralong biological activity. Proc Natl Acad Sci U S A 77:5754–5758CrossRefPubMedGoogle Scholar
  25. 25.
    Schiller M, Raghunath M, Metze D et al (2001) Human dermal fibroblasts in vitro express the PC1 and PC2 and produce the POMC-derived peptides. J Invest Dermatol 117:227–235CrossRefPubMedGoogle Scholar
  26. 26.
    Schiller M, Brzoska T, Böhm M et al (2004) Solar-simulated UVR-induced upregulation of the melanocortin-1 receptor, pro-opiomelanocortin and α-melanocyte-stimulating hormone in human epidermis in vivo. J Invest Dermatol 122:468–476CrossRefPubMedGoogle Scholar
  27. 27.
    Scholzen T, Kalden DH, Brzoska T et al (2000) Expression of proopiomelanocortin peptides in human dermal microvascular endothelial cells: evidence for a regulation by ultraviolet light and interleukin-1. J Invest Dermatol 115:1021–1028CrossRefPubMedGoogle Scholar
  28. 28.
    Scholzen TE, Sunderkotter C, Kalden DH et al (2003) Alpha-melanocyte stimulating hormone prevents lipopolysaccharide-induced vasculitis by down-regulating endothelial cell adhesion molecule expression. Endocrinology 144:360–370CrossRefPubMedGoogle Scholar
  29. 29.
    Seidah NG, Benjannet S, Hamelin J et al (1999) The subtilisin/kexin family of precursor convertases. Emphasis on PC1, PC2/7B2, POMC and the novel enzyme SKI-1. Ann N Y Acad Sci 885:57–74PubMedGoogle Scholar
  30. 30.
    Song X, Mosby N, Yang J et al (2009) alpha-MSH activates immediate defense responses to UV-induced oxidative stress in human melanocytes. Pigment Cell Melanoma Res 22:809–818CrossRefPubMedGoogle Scholar
  31. 31.
    Slominski A, Wortsman J, Luger T et al (2000) Corticotropin releasing hormone and proopiomelanocortin involvement in the cutaneous response to stress. Physiol Rev 80:979–1020PubMedGoogle Scholar
  32. 32.
    Spencer JD, Gibbons NC, Rokos H et al (2007) Oxidative stress via hydrogen peroxide affects proopiomelanocortin peptides directly in the epidermis of patients with vitiligo. J Invest Dermatol 127:411–420CrossRefPubMedGoogle Scholar
  33. 33.
    Spencer JD, Schallreuter KU (2009) Regulation of pigmentation in human epidermal melanocytes by functional high-affinity beta-melanocyte-stimulating hormone/melanocortin-4 receptor signaling. Endocrinology 150:1250–1258CrossRefPubMedGoogle Scholar
  34. 34.
    Sturm RA, Duffy DL, Box NF et al (2003) Genetic association and cellular function of MC1R variant alleles in human pigmentation. Ann N Y Acad Sci 994:348–358CrossRefPubMedGoogle Scholar
  35. 35.
    Zhang L, Li WH, Anthonavage M, Eisinger M (2006) Melanocortin-5 receptor: a marker of human sebocyte differentiation. Peptides 27:413–420CrossRefPubMedGoogle Scholar
  36. 36.
    Mastrofrancesco A, Kokot A, Eberle A et al (in Revision) KdPT, a tripeptide derivative of α-MSH, is a suppressor of proinflammatory cytokine expression and signaling in human sebocytes. J ImmunolGoogle Scholar
  37. 37.
    Bettenworth D, Böhm M, Mennigen R et al. (eingereicht) The tripeptide KdPT protects from intestinal inflammation by maintaining intestinal barrier function. J Am PatholGoogle Scholar

Copyright information

© Springer-Verlag 2010

Authors and Affiliations

  1. 1.Klinik und Poliklinik für Hautkrankheiten – Allgemeine Dermatologie und VenerologieUniversitätsklinikum MünsterMünsterDeutschland

Personalised recommendations